Clinical trial / 2009
A 6-month Ma-Pi 2 macrobiotic diet intervention improved glycemic control, lipid profiles, and reduced medication use in type 2 diabetes.
A 6-month dietary intervention evaluated the Ma-Pi 2 macrobiotic diet in 16 adults with type 2 diabetes and HbA1 >8.5%. At 6 months, anthropometric variables were significantly lower while lean mass was preserved, and all participants were able to eliminate insulin treatment (25% continued glibenclamide only). Mean total cholesterol, LDL cholesterol, and triglycerides fell by 16.4%, 22.7%, and 37.0%, respectively, HDL rose by 97.8%, and mean glycemia and HbA1 dropped by 63.8% and 54.5%, respectively. The authors note that further research is needed to validate results, particularly a clinical trial with a standard diet control group.
- Study type
- 6-month dietary intervention trial
- Who was studied
- 16 adults with type 2 diabetes mellitus and poor glucide metabolism control (HbA1 >8.5%) in Cuba
- What was measured
- Anthropometric variables, glucide and lipid metabolism, nutritional safety variables, and hypoglycemic medication use
THE PAPER
Ma-pi 2 macrobiotic diet intervention in adults with type 2 diabetes mellitus.
Porrata C, Sánchez J, Correa V, Abuín A, Hernández-Triana M, Dacosta-Calheiros RV, Díaz ME, Mirabal M, Cabrera E, Campa C, Pianesi M. MEDICC Rev, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.